Shanghai - Delayed Quote CNY
InventisBio Co., Limited (688382.SS)
At close: 3:00 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
120,400.08
185,526.87
--
--
--
Gross Profit
114,082.81
185,526.87
--
--
--
Operating Expense
471,397.02
500,736.34
519,444.14
357,943.63
--
Operating Income
-357,314.21
-315,209.48
-519,444.14
-357,943.63
--
Net Non Operating Interest Income Expense
39,629.44
32,845.88
15,112.41
11,405.18
431.62
Pretax Income
-330,444.23
-283,975.27
-483,485.01
-357,911.47
-1,053,448.80
Net Income Common Stockholders
-330,444.23
-283,975.27
-483,485.01
-357,911.47
-1,053,448.80
Basic EPS
-0.57
-0.49
-0.95
-0.78
-2.29
Diluted EPS
-0.57
-0.49
-0.95
-0.78
-2.29
Basic Average Shares
579,802.54
579,541.38
508,931.59
458,860.87
460,021.31
Diluted Average Shares
579,802.54
579,541.38
508,931.59
458,860.87
460,021.31
Total Operating Income as Reported
-330,444.23
-283,975.27
-483,305.48
-357,911.47
-1,053,448.80
Rent Expense Supplemental
380.55
256.24
492.25
484.47
2,559.36
Total Expenses
477,714.29
500,736.34
519,444.14
357,943.63
--
Net Income from Continuing & Discontinued Operation
-330,444.23
-283,975.27
-483,485.01
-357,911.47
-1,053,448.80
Normalized Income
-314,318.54
-274,628.02
-483,490.51
-357,865.53
-1,053,448.80
Interest Income
39,742.87
33,894.35
17,379.10
12,763.86
555.09
Interest Expense
--
182.89
1,031.52
1,191.27
--
Net Interest Income
39,629.44
32,845.88
15,112.41
11,405.18
431.62
EBIT
-341,120.58
-283,792.39
-482,453.49
-356,720.21
--
EBITDA
-323,966.01
-266,133.08
-466,840.46
-345,615.75
414.44
Reconciled Depreciation
17,154.57
17,659.30
15,613.03
11,104.46
414.44
Net Income from Continuing Operation Net Minority Interest
-330,444.23
-283,975.27
-483,485.01
-357,911.47
-1,053,448.80
Total Unusual Items Excluding Goodwill
-16,125.69
-9,347.26
5.50
-45.95
212.05
Total Unusual Items
-16,125.69
-9,347.26
5.50
-45.95
212.05
Normalized EBITDA
-307,840.32
-256,785.82
-466,845.95
-345,569.80
414.44
12/31/2020 - 7/25/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
688062.SS Mabwell (Shanghai) Bioscience Co., Ltd.
22.15
-3.15%
688578.SS Shanghai Allist Pharmaceuticals Co., Ltd.
51.60
-0.71%
2256.HK Abbisko Cayman Limited
4.150
+4.53%
2162.HK Keymed Biosciences Inc.
41.550
+1.09%
2511.HK HighTide Therapeutics, Inc.
1.180
0.00%
1530.HK 3SBIO
5.830
-1.69%
6855.HK Ascentage Pharma Group International
43.200
-4.00%
ANL Adlai Nortye Ltd.
2.0500
+0.49%
9969.HK InnoCare Pharma Limited
6.610
-0.30%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
172.900
-0.80%